{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:58:09Z","timestamp":1783339089193,"version":"3.54.6"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.vaccine.2020.12.045","type":"journal-article","created":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T08:23:46Z","timestamp":1608884626000},"page":"678-681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Reports of cell-based influenza vaccine administered during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2013\u20132020"],"prefix":"10.1016","volume":"39","author":[{"given":"Pedro L.","family":"Moro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2020.12.045_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6908a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices \u2013 United States, 2020\u201321 influenza season","volume":"69","author":"Grohskopf","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2020.12.045_b0010","unstructured":"Food and Drug Administration. November 20, 2012 Approval Letter \u2013 Flucelvax. Available at: http:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm328684.htm."},{"key":"10.1016\/j.vaccine.2020.12.045_b0015","unstructured":"Food and Drug Administration. July 7, 2017 Approval Letter \u2013 Flucelvax. Available at: https:\/\/www.fda.gov\/media\/106242\/download."},{"key":"10.1016\/j.vaccine.2020.12.045_b0020","unstructured":"Flucelvax Quadrivalent [Package Insert]. Holly Springs, NC: Seqirus; 2020."},{"issue":"36","key":"10.1016\/j.vaccine.2020.12.045_b0025","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.12.045_b0030","unstructured":"Medical dictionary for regulatory activities. Available at: http:\/\/www.meddramsso.com\/ [accessed August 20, 2020]."},{"key":"10.1016\/j.vaccine.2020.12.045_b0035","unstructured":"International conference on harmonisation of technical requirements for registration of pharmaceuticals. http:\/\/www.ich.org\/products\/meddra.html."},{"key":"10.1016\/j.vaccine.2020.12.045_b0040","unstructured":"Food and Drug Administration. 21 CFR Part 600.80. Postmarketing reporting of adverse experiences. Vol 62: Federal Register, 1997:52252\u20133."},{"key":"10.1016\/j.vaccine.2020.12.045_b0045","unstructured":"Cunningham G, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY, editors. Williams obstetrics. New York (NY): McGraw-Hill Companies, Inc; 2010."},{"key":"10.1016\/j.vaccine.2020.12.045_b0050","unstructured":"Flucelvax Pregnancy Registry. Clinicaltrials.gov NCT03438487 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03438487."},{"issue":"2","key":"10.1016\/j.vaccine.2020.12.045_b0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40264-016-0482-1","article-title":"Surveillance of adverse events after seasonal influenza vaccination in pregnant women and their infants in the vaccine adverse event reporting system, July 2010\u2013May 2016","volume":"40","author":"Moro","year":"2017","journal-title":"Drug Saf"},{"issue":"5","key":"10.1016\/j.vaccine.2020.12.045_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.06.047","article-title":"Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System","volume":"205","author":"Moro","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"20","key":"10.1016\/j.vaccine.2020.12.045_b0065","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.vaccine.2016.03.049","article-title":"Enhanced surveillance of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines in pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2011\u20132015","volume":"34","author":"Moro","year":"2016","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20316133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20316133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:50:59Z","timestamp":1759402259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20316133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0264410X20316133"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.12.045","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reports of cell-based influenza vaccine administered during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2013\u20132020","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.12.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}